Acute Myeloid Leukemia Reported 32 Months After Icotinib Therapy for EGFR-Mutated Lung Cancer
A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for EGFR-mutated lung cancer, ...
Tag: PPM1D mutation
POPULAR NEWS
-
Acute Myeloid Leukemia Reported 32 Months After Icotinib Therapy for EGFR-Mutated Lung Cancer
-
Behavioural programmes for diabetes and hypertension in South Asia skew toward education, review finds
-
Matrigel Scaffold Improves Wound Repair in Mice, With Modest Cell Boost
-
Osteoporosis Drug Denosumab Outperforms Zoledronic Acid for Muscle Strength Over Three Years